# Nevro acquires Vyrsa Technologies for up to $75M

Nevro Corp. acquired Vyrsa Technologies, a medical device company focused on sacroiliac joint fusion devices, for $40 million at closing plus up to $35 million in milestone payments. The transaction closed on November 30, 2023.

- Type: Acquisition
- Announced: 2023-11-30
- Where: United States
- Value: $40.0M
- Status: completed
- Products: sacroiliac joint fusion devices
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Nevro](https://endata.com/companies/49893.md) (acquirer)
- [Vyrsa Technologies](https://endata.com/companies/74080.md) (target)

## Sources

- [intl.nevro.com](https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2023/Nevro-Announces-Acquisition-of-Vyrsa-Technologies/default.aspx), 2023-11-30: "The acquisition of Vyrsa leverages Nevro's ability to drive long-term shareholder value by accelerating our key strategic initiatives of commercial execution, market penetration, and profit progress."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.